6Collart P, Coppieters Y, Leveque A. Trends in acute myocardial infarction treatment between1998 and 2007 in a Belgian area (Charleroi) EJI. Eur J Prev Cardiol, 2012, 19 (4) : 738-745.
7Prasad S, Kashyap RS, Deopujar JY, et al. Development of an in vitro model to study clot lysis activity of thrombolytic drugs [Jl. Thromb J, 2006, 4: 14.
8Collen D, Lijnen HR. Basic and clinical aspects of fibrinolysis and thrombolysis EJ]. Blood, 1991, 78 (12) : 3114-3124.
9Perler B. Thrombolytic therapies: the current state of affairs [J]. J Endovasc Ther, 2005, 12 (2) : 224-232.
10Qureshi AI, Pande RU, Kim SH, et al. Third generation thrombolytics for the treatment of ischemic stroke [J]. Curr Opin Investig Drugs, 2002, 3 (12) : 1729-1732.